Quest Diagnostics Incorporated (DGX) vs West Pharmaceutical Services, Inc. (WST)
A side-by-side comparison of Quest Diagnostics Incorporated and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.
DGX
Quest Diagnostics Incorporated
$237.51HealthcareDelayed quote: Aug 11, 2026, 3:59 PM EDT
WST
West Pharmaceutical Services, Inc.
$351.25HealthcareDelayed quote: Aug 11, 2026, 3:59 PM EDT
Total return — DGX vs WST
growth of $100 · dividends reinvested · last 10yDGX +239.0% (+13.0%/yr)WST +352.0% (+16.3%/yr)WST compounded faster over this window
DGX WST
DGX vs WST: by the numbers
- •DGX is the larger company ($26.21B vs $24.72B market cap).
- •DGX trades at the lower trailing earnings multiple (25.23 vs 45.03 P/E), one valuation lens rather than an overall verdict.
- •WST converts more revenue to profit (16.98% vs 9.19% net margin).
- •WST grew revenue faster over the past five years (5.68% vs 0.89% CAGR).
- •DGX pays the higher dividend yield (1.40% vs 0.25%).
Metrics side by side
Valuation
| Metric | DGX | WST |
|---|---|---|
| P/E ratio | 25.23 | 45.03 |
| Forward P/E | 21.23 | 39.38 |
| P/S ratio | 2.30 | 7.55 |
| P/B ratio | 3.54 | 8.40 |
| EV / EBITDA | 16.21 | 28.82 |
| FCF yield | 4.58% | 1.74% |
Profitability
| Metric | DGX | WST |
|---|---|---|
| Gross margin | 33.15% | 36.77% |
| Operating margin | 14.14% | 20.64% |
| Net margin | 9.19% | 16.98% |
| ROE | 14.13% | 18.89% |
| ROIC | 8.43% | 13.62% |
Dividends
| Metric | DGX | WST |
|---|---|---|
| Dividend yield | 1.40% | 0.25% |
| Payout ratio | 37.43% | 12.88% |
Growth (annualized)
| Metric | DGX | WST |
|---|---|---|
| Revenue CAGR (5Y) | 0.89% | 5.68% |
| EPS CAGR (5Y) | -3.65% | 7.85% |
| FCF CAGR (5Y) | -10.89% | 8.74% |
| Total return CAGR (5Y) | 12.01% | -3.44% |
Frequently asked
- Which has the lower trailing P/E, DGX or WST?
- DGX has the lower trailing P/E: DGX trades at 25.23 and WST at 45.03. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, DGX or WST?
- Over the past five years, WST grew revenue faster — DGX at a 0.89% CAGR versus WST at 5.68%.
- Does DGX or WST pay a bigger dividend?
- DGX yields 1.40% and WST yields 0.25% based on trailing dividends and the latest price.
- Is DGX or WST more profitable?
- WST runs the higher net margin — DGX at 9.19% versus WST at 16.98%.
- How have DGX and WST total returns compared?
- Over the past 10 years, DGX delivered 12.99% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioWest Pharmaceutical Services P/E ratioQuest Diagnostics dividend yieldWest Pharmaceutical Services dividend yieldQuest Diagnostics ROEWest Pharmaceutical Services ROEQuest Diagnostics operating marginWest Pharmaceutical Services operating marginQuest Diagnostics revenue growthWest Pharmaceutical Services revenue growthQuest Diagnostics free cash flowWest Pharmaceutical Services free cash flow
Quest Diagnostics & West Pharmaceutical Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.